tolvaptan — United Healthcare
clinically significant hypervolemic hyponatremia
Initial criteria
- Diagnosis of clinically significant euvolemic hyponatremia OR clinically significant hypervolemic hyponatremia
- Patient has not responded to fluid restriction
- Treatment has been initiated or re-initiated in a hospital setting prior to discharge
Approval duration
30 days